Best Asian Stocks To Watch For 2014

LONDON -- The FTSE 100 (FTSEINDICES: ^FTSE  ) perked up a bit yesterday to end the day on 6,558 points, but it has turned tail again today to fall 95 points, or 1.44%, to 6,464 by 9:30 a.m. EDT. Despite the apparent lessening of fears concerning the possible end of economic stimulus measures, a weak session in Asian markets led to a bearish opening in London. Until we get concrete updates on American and European monetary policies, the market looks likely to continue in this uncertain manner.

So which companies are leading the FTSE down? Here are three names that are slipping and look set to lag the index today.

Tesco
Tesco shares have fallen 4.6% after the U.K.'s biggest supermarket chain revealed a fall in like-for-like sales in its first-quarter update.�In the U.K., we saw a 1% fall, but in other markets things were worse, down 3.8% in Asia and down a scary 5.5% in Europe (all excluding petrol sales). Total group sales were actually up 2.7%, but in like-for-like terms that translated to a fall of 2.2%.

Best Clean Energy Companies To Invest In 2015: Groupe Steria SCA (RIA)

Groupe Steria SCA is a France-based holding company engaged in the provision of end-to-end information technology (IT) services. The Company�� business is divided into four segments: Systems Integration, offering design and development of system; Application Management, providing maintenance and supervision of the stages in the life cycle of software applications; Management of IT Infrastructure, providing technical and business assistance, supervision of systems and network infrastructures, administration and operation of systems and network infrastructures, and hosting infrastructures in data centers; and Business Process Outsourcing (BPO), providing taking over the operation of part or all of business function on behalf of the customer. The Company is operational mainly in the United Kingdom, France, Germany and other European countries. The Company has subsidiaries in France, Morocco, the United Kingdom, India, Germany, Austria and Poland, among others. Advisors' Opinion:

• [By victorselva]

  The Charles Schwab Corporation (SCHW) is a savings and loan holding company. The company is engaged, through its subsidiaries, in securities brokerage, banking, money management, and financial advisory services. Its subsidiaries include Charles Schwab & Co. (a leading discount broker-dealer), Charles Schwab Investment Management (a mutual fund investment advisor) and Charles Schwab Bank.In this article, let's take a look at this brokerage firm and try to explain to investors the reasons this is an apparently appealing investment opportunity.The FocusThe company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services. The Investor Services segment provides retail brokerage and banking services to individual investors. The Institutional Services segment provides custodial, trading, and support services to independent investment advisors. The Institutional Services segment also provides retirement plan services, specialty brokerage services, and mutual fund clearing services. The company seeks to meet the financial services needs of investors, advisers and employers. It focuses on building client loyalty with the goal of attracting new clients and serving them. Additionally, Schwab麓s strengths through shared core processes and technology advances which help create services that are scalable and consistent with the business.Interest Rates, Capital Structure and Debt-to-Capital RatioThe results are dependent on short-term interest rates, as 37% of its top line came from net interest income in the first quarter of 2014.The broker has been making significant efforts to become less dependent on interest rates, which we expect Federal Reserve will raise them in late 2014 or 2015. Also, the company麓s plan is to reach a low-cost capital structure and targets a long-term debt-to-total financial capital ratio of less than 30%.Lucrative Derivatives Trading In 2011, the company acquired Compl

Best Asian Stocks To Watch For 2014: Hanmi Financial Corporation(HAFC)

Hanmi Financial Corporation operates as the holding company for Hanmi Bank that provides general business banking products and services in the United States. Its deposit product line comprises business and personal checking accounts, savings accounts, negotiable order of withdrawal accounts, money market accounts, and certificates of deposit. The company?s loan portfolio includes real estate loans, such as commercial property, construction, and residential property loans; commercial and industrial loans comprising commercial term loans, commercial lines of credit, small business administration loans, and international trade finance; and consumer loans consisting of automobile loans, secured and unsecured personal loans, home improvement loans, home equity lines of credit, overdraft protection loans, and unsecured lines of credit and credit cards. It also offers various insurance products, such as life, commercial, automobile, health, and property and casualty. The company serves the Korean-American community, as well as other communities in the multi-ethnic populations of Los Angeles County, Orange County, San Bernardino County, San Diego County, the San Francisco Bay area, and the Silicon Valley area in Santa Clara County. As of December 31, 2010, it operates a branch network of 27 full-service branch offices in California and one loan production office in Washington. Hanmi Financial Corporation was founded in 1981 and is headquartered in Los Angeles, California.

Advisors' Opinion:

• [By GuruFocus]

  Hanmi Financial Corporation (HAFC): President and CEO Chong Guk Kum Bought 1,821 Shares
  
  President and CEO of Hanmi Financial Corporation (HAFC) Chong Guk Kum bought 1,821 shares on 09/20/2013 at an average price of $16.27. Hanmi Financial Corporation has a market cap of $513.615 million; its shares were traded at around $16.27 with a P/E ratio of 10.95 and P/S ratio of 3.82. The dividend yield of Hanmi Financial Corporation stocks is 0.43%.

Best Asian Stocks To Watch For 2014: Banco Santander Brasil SA (BSBR)

Banco Santander (Brasil) S.A. (Santander Brasil), incorporated on August 9, 1985, is a full-service bank in Brazil. The Bank operates its business along three segments: Commercial Banking, Global Wholesale Banking and Asset Management and Insurance. Through its Commercial Banking segment, the Bank offers traditional banking services, including checking and savings accounts, home and automobile financing, unsecured consumer financing, checking account overdraft loans, credit cards and payroll loans to mid- and high-income individuals and corporations (other than to its Global Banking and Markets clients). Its Global Wholesale Banking segment provides financial services and solutions to a group of approximately 700 local and multinational conglomerates, offering such products as global transaction banking, syndicated lending, corporate finance, equity and treasury. Through its Asset Management and Insurance segment, the Company manages fixed income, money market, equity and multi-market funds and offers insurance products complementary to its core banking business to its retail and small- and medium-sized corporate customers.

Lending Activities

As of December 31, 2010, the Bank�� total loans and advances to customers equaled R$160.6 billion (42.9% of its total assets). Net of allowances for credit losses, loans and advances to customers equaled R$151.4 billion as of December 31, 2010 (40.4% of its total assets). In addition to loans, it had outstanding R$93.5 billion as of December 31, 2010.

Substantially all of its loans are to borrowers domiciled in Brazil and are denominated in reais. Its commercial, financial and industrial loans include primarily loans to small and medium-sized enterprises (SMEs) in its Commercial Banking segment, and to Global Banking and Markets corporate and business enterprise customers in its Wholesale Global Banking segment. The principal products offered to SMEs in this category include revolving loans, overdraft facilities, installme! nt loans, working capital and equipment finance loans. Credit approval for SMEs is based on customer income, business activity, collateral coverage and internal and external credit scoring tools. Collateral on commercial, financial and industrial lending to SMEs generally includes receivables, liens, pledges, guarantees and mortgages, with coverage generally ranging from 100% to 150% of the loan value depending on the risk profile of the loan. Its Wholesale Global Banking customers are offered a range of loan products ranging from typical corporate banking products (installment loans, working capital and equipment finance loans) to more sophisticated products (derivative and capital markets transactions).

The Bank�� Real estate-construction loans include construction loans made principally to real estate developers that are SMEs and corporate customers in its Wholesale Global Banking Segment. Loans in this category are generally secured by mortgages and receivables, though guarantees may also be provided as additional security. Real estate-mortgage loans include loans on residential real estate to individuals. All loans granted under this category are secured by the financed real estate. Installment loans to individuals consist primarily of unsecured personal installment loans (including loans whose payments are automatically deducted from a customer�� payroll), revolving loans, overdraft facilities, consumer finance facilities and credit cards. Lease financing includes primarily automobile leases and loans to individuals. The vehicle financed acts as collateral for the particular loan granted.

Investment Activities

The Bank�� investments include Government securities-Brazil, Government securities-other countries and other debt securities. As of December 31, 2010, the book value of the investment securities was R$84.7 billion (representing 22.6% of its total assets). Brazilian government securities totaled R$55.8 billion, or 65.9% of the Bank�� investment! securiti! es as of December 31, 2010. As of December 31, 2010, the Bank held no securities of single issuers or related group of companies whose aggregate book or market value exceed 10% of stockholders��equity, other than Brazilian government securities, which represented 76.9% of its stockholders��equity.

Sources of Funds

The Bank offers its customers a variety of deposit products, such as current accounts (also referred to as demand deposits), which do not bear interest; traditional savings accounts, which earn the Brazilian reference rate for savings accounts (taxa referencial) plus 0.5% per month, as set by the federal government, and time deposits, which are represented by certificates of bank deposits (CDBs), which normally have a maturity of less than 36 months and earn interest at a fixed or floating rate. In addition, it accepts deposits from financial institutions as part of its treasury operations, which are represented by certificates of interbank deposit CDIs, and which earn the interbank deposit rate.

Advisors' Opinion:

• [By WWW.DAILYFINANCE.COM]

  www.blackcard.com Black cards are the most exclusive credit cards on the market, and these rare credit cards are in the pockets of some of the wealthiest citizens around the world. Here's what it takes -- and what you can get. 1. Eurasian Bank Diamond Card Featuring a 0.02-carat diamond surrounded by a golden heart design, the Eurasian Bank Diamond Card is a sign of wealth and elegance through and through. The black card requirements for this exclusive credit card is you have to be a member of the Eurasian bank in Kazakhstan, and you also have to have $300,000 or more in your bank account. 2. The Visa (V) Signature Card Visa's true top of the line card is the Visa Signature Card, which features some amazing perks like no preset spending limits; access to special sporting events and concert tickets; VIP access to entertainment venues like Broadway shows and musicals; travel accommodations at spas, hotels and with airlines; and special dining experiences. 3. The Chase (JPM) Sapphire Preferred Card For those who look for exclusivity but prefer not to bank with Visa or Amex (AXP), there is the Chase Sapphire Preferred Card. The Preferred Card is aimed at households in the United States earning at least $120,000 per year. Big perks include no preset spending limit and a strong rewards program for members. Other notable differences from other black card offerings include: Identity protection; a small $95 per year fee; enhanced travel rewards redemption points; rental insurance; travel protection insurance; emergency travel assistance and extended warranty protection for up to one year. 4. The Black Brazilian MasterCard (MA) from the Santander Group The Santander Group (BSBR) in Brazil offers the unlimited Brazilian Black MasterCard, which is only issued to members of its private bank with a certain undisclosed amount of funds in their accounts. Currently, it is one of the hottest cards in Latin America -- with only about 3,000 in circulation. Perks of the c

• [By Rudy Martin]

  We are buying Banco Santander (Brasil) S.A. (BSBR) to gain broad additional exposure to the Brazilian.

  BSBR offers a full-service range of financial services, including individual and corporate banking. We also hope to benefit from the stock's 7.2% current indicated dividend yield.

• [By Jake L'Ecuyer]

  Banco Santander (Brasil) SA (NYSE: BSBR) shares were also up, gaining 12.46 percent to $6.50 on Q1 results. The company reported Q1 recurring net income of 1.427 billion reais ($637 million).

Best Asian Stocks To Watch For 2014: Yappn Corp (YPPN)

Yappn Corp., formerly Plesk Corp., incorporated on November 3, 2010, is focusing on social media Website that will host multi-language conversations based on different topics, such as interests, brands and activities. Its platform will enable users to meet people from all over the world without any language barriers and to interact with them through online chatting and forums by providing access to topical discussion boards in almost 70 languages. This will permit real-time multiple language conversations to co-exist without the fracturing that comes as a result of many people posting in multiple languages to a single chat area or splintering the audience by segregating posts by language. Yappn is a topic or interest focused site bringing people together to discuss current events, celebrities, technology, sports, entertainment and other popular areas of conversation. On March 28, 2013, it purchased social media platform and related group of assets known as Yappn.

The Company will have gamification system that will reward users for their engagement through virtual trophies, badges, and medals for participation in selected events. The Company, with the power of Ortsbo offers a set of communication tools where users can create opportunities to meet, chat, engage and consume in their own virtual location creating global social engagement for private events and closed networks. Users can also connect to social networks and engage friends and followers on Facebook, Yahoo, Twitter and more. It will be available on all devices through mobile, portable and desktop online access. With Yappn, user generated content be closed captioned in multiple languages in minutes, using Ortsbo�� pending business processes and tools for a translation experience. Commercial enterprises can use its Website to communicate their content, their e-commerce offerings and other messaging on a global scale.

The Company competes with Facebook, LinkedIn, Craigslist, Google and Apple.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Digital Caddies Inc (OTCMKTS: CADY), MEDL Mobile Holdings Inc (OTCMKTS: MEDL) and Yappn Corp (OTCMKTS: YPPN) offer different ways to potentially profit from Internet or mobile technology. However, all three small cap stocks have also been the subject of paid promotions or investor relations types of activities. So will investors actually profit from the efforts of these small caps to profit from the Internet or mobile technology? Here is a quick reality check:

Best Asian Stocks To Watch For 2014: Horizon Pharma Inc (HZNP)

Horizon Pharma, Inc. (Horizon), incorporated on March 23, 2010, is a biopharmaceutical company that develops and commercializes medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. On April 23, 2011, the United States Food and Drug Administration, approved DUEXIS (formerly HZT-501), a tablet formulation containing a fixed-dose combination of ibuprofen and famotidine in a single pill. The Company�� other product, LODOTRA (NP-01), is a programmed release formulation of low-dose prednisone that is marketed in Europe by the Company�� distribution partner, Mundipharma International Corporation Limited (Mundipharma). As of December 31, 2010, Horizon completed multiple Phase III clinical trials of LODOTRA. In addition to these product candidates, the Company has a pipeline of earlier-stage product candidates to treat pain-related diseases and chronic inflammation. On April 1, 2010, Horizon effected a recapitalization and acquisition pursuant to which Horizon Pharma, Inc. became a holding company, that operates through its wholly owned subsidiaries, Horizon Pharma USA, Inc. (formerly Horizon Therapeutics, Inc.) and Horizon Pharma AG (formerly Nitec Pharma AG (Nitec)).

DUEXIS

DUEXIS is a combination of 800 milligram ibuprofen and 26.6 milligram famotidine in a single pill and is indicated for the relief of signs and symptoms of rheumatoid arthritis (RA), and osteoarthritis (OA), and to decrease the risk of developing upper gastrointestinal (GI), ulcers in patients who are taking ibuprofen for those indications. The Company has completed two Phase III clinical trials in a total of over 1,500 patients with mild to moderate pain or arthritis that demonstrated a significant reduction in the incidence of non-steroidal anti-inflammatory drugs (NSAID)-induced upper GI ulcers when treated with DUEXIS versus ibuprofen alone.

LODOTRA

LODOTRA is a programmed release formulation of low-dose prednisone, a well-established drug use! d to inhibit the production of various pro-inflammatory cytokines, which are proteins associated with joint inflammation in RA. LODOTRA has received regulatory approval in Europe for the treatment of moderate to severe, active RA in adults when accompanied by morning stiffness. As of December 31, 2010, the Company had completed two pivotal Phase III clinical trials of LODOTRA in a total of over 600 patients with RA. The first pivotal Phase III trial supported the approval of LODOTRA in Europe in March 2009, where it is approved for marketing in 14 European countries. LODOTRA achieved significant results and met the primary endpoint in each of the two pivotal Phase III clinical trials. Its LODOTRA product was developed and is owned by Horizon Pharma AG. As of December 31, 2010, the Company markets LODOTRA in Europe through three separate agreements. Pursuant to two separate agreements, it granted Merck Serono GmbH and Merck GesmbH, an affiliate of Merck Serono, the rights to distribute and market LODOTRA in each of Germany and Austria, respectively, and pursuant to the third agreement, it granted Mundipharma rights to distribute and market LODOTRA in the rest of Europe. The Company also has a manufacturing and supply agreement with Jagotec AG under which Jagotec or its affiliates manufacture and supply LODOTRA to the Company as bulk tablets.

The Company competes with Pfizer Inc., Pozen Inc., Abbott Laboratories and Amgen Inc.

Advisors' Opinion:

• [By Bryan Murphy]

  After a 16% rally on Tuesday, it would be understandable is a newcomer wanted to steer clear of Horizon Pharma Inc. (NASDAQ:HZNP). After all, how much more upside can there be for this fairly typical small cap biotech stock. Yet, HZNP may well be one of the rare exceptions to the "tough to follow-through" tendency.
  
  For those not familiar, HZNP is a biopharma name with a couple of rheumatoid arthritis, COPD, and asthma drugs on the market... Duexis, and Rayos. There's a third drug in the pipeline - Lodotra, for polymyalgia rheumatica, though it's already approved as a treatment for RA.� Either way, Horizon Pharma Inc. is unique in the sense that though it's a small biopharma company, it's at least driving revenue with a handful of marketable products.
  
  The pipeline and portfolio are secondary at this point, however. What matters most to traders now is whether or not there's actually any upside left to tap into with Horizon Pharma. The answer is, it depends.
  
  Given just the nearby daily chart, no, it looks like HZNP has burned up all of its fuel. Aside from the fact that it's overextended now, Tuesday's volume spike also implies anybody who was thinking about buying went ahead and took the plunge. That may well mean nobody is left to keep buying tomorrow. There may well be, however, plenty of nervous-Nellie profit-takers ready to head for the exit.
  
  The assessment changes quite a bit when you zoom out to a longer-term chart of Horizon Pharma, though.
  
  While this won't allow the stock to sidestep a near-term pullback, Tuesday's pop was something a game-changer for the long-term chart. The move shook the stock out of a narrow range that had trapped the stock between $2.80 and $2.12 for the last ten months.
  
  
  
  The proverbial "so what" is, with nearly a years' worth of pent-up energy finally being unleashed, we're nowhere near the end of the final resting place. Once we burn off this initial, knee-jerk reaction to the